Screener
Amphastar Pharmaceuticals AMPH Interest Expense
Interest Expense at other companies
Other financials
Where this comes from
Reported directly by Amphastar Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:InterestExpenseNonoperating.
The source filing: Amphastar Pharmaceuticals’s 10-Q, filed August 6, 2026.
- Filed
- Aug 6, 2026, 4:50 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001297184-26-000047
| Line item | Three Months Ended / June 30, 2026 | Three Months Ended / June 30, 2025 | Six Months Ended / June 30, 2026 | Six Months Ended / June 30, 2025 |
|---|---|---|---|---|
| Income from operations | 39,729 | 42,184 | 53,359 | 79,477 |
| Non-operating expenses: | ||||
| Interest income | 2,287 | 1,921 | 4,687 | 4,010 |
| Interest expense | (6,659) | (6,281) | (13,212) | (12,567) |
| Other income (expenses), net | 3,187 | 1,511 | 3,762 | (723) |
| Total non-operating expenses, net | (1,185) | (2,849) | (4,763) | (9,280) |
| Income before income taxes | 38,544 | 39,335 | 48,596 | 70,197 |
| Income tax provision | 8,196 | 8,305 | 11,828 | 13,882 |
Item 1. Financial Statements (unaudited)
FAQ
- What is Amphastar Pharmaceuticals's interest expense?
- Amphastar Pharmaceuticals (AMPH) reported interest expense of $6.66M in Q2 2026.
- How has Amphastar Pharmaceuticals's interest expense changed year-over-year?
- Amphastar Pharmaceuticals's interest expense increased by 6.0% year-over-year, from $6.28M to $6.66M.
- What is the long-term trend for Amphastar Pharmaceuticals's interest expense?
- Over 4 years (2021 to 2025), Amphastar Pharmaceuticals's interest expense has grown at a 131.6% compound annual growth rate (CAGR), from $885K to $25.48M.
- What does interest expense mean?
- Cost of borrowing — interest paid or accrued on bonds, bank loans, credit facilities, finance leases, and other debt obligations.
Ask your AI about Amphastar Pharmaceuticals's interest expense.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude